NO20070299L - Novel heterocyclic compounds - Google Patents
Novel heterocyclic compoundsInfo
- Publication number
- NO20070299L NO20070299L NO20070299A NO20070299A NO20070299L NO 20070299 L NO20070299 L NO 20070299L NO 20070299 A NO20070299 A NO 20070299A NO 20070299 A NO20070299 A NO 20070299A NO 20070299 L NO20070299 L NO 20070299L
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic compounds
- novel heterocyclic
- novel
- compounds
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN745MU2004 | 2004-07-12 | ||
| PCT/IN2005/000237 WO2006025069A2 (en) | 2004-07-12 | 2005-07-08 | Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20070299L true NO20070299L (no) | 2007-03-26 |
Family
ID=35636669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20070299A NO20070299L (no) | 2004-07-12 | 2007-01-17 | Novel heterocyclic compounds |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8030345B2 (no) |
| EP (2) | EP1781668A2 (no) |
| JP (1) | JP2008505965A (no) |
| KR (1) | KR20070041717A (no) |
| CN (1) | CN101014605A (no) |
| AP (1) | AP2228A (no) |
| AU (1) | AU2005278781B2 (no) |
| BR (1) | BRPI0513104A (no) |
| CA (1) | CA2586011C (no) |
| EA (1) | EA011307B1 (no) |
| EC (1) | ECSP077167A (no) |
| GE (1) | GEP20094682B (no) |
| IL (1) | IL180637A0 (no) |
| MX (1) | MX2007000491A (no) |
| NO (1) | NO20070299L (no) |
| NZ (2) | NZ552670A (no) |
| TN (1) | TNSN07006A1 (no) |
| UA (1) | UA88910C2 (no) |
| WO (1) | WO2006025069A2 (no) |
| ZA (1) | ZA200700162B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1781668A2 (en) * | 2004-07-12 | 2007-05-09 | Cadila Healthcare Ltd. | Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| IN2012DN02474A (no) | 2009-08-28 | 2015-08-21 | Arena Pharm Inc | |
| US9597340B2 (en) | 2011-02-25 | 2017-03-21 | Arena Pharmaceuticals, Inc. | Cannabinoid receptor modulators |
| US20140206649A1 (en) | 2011-02-25 | 2014-07-24 | Jayant Thatte | Cannabinoid receptor modulators |
| JP5945554B2 (ja) | 2011-02-25 | 2016-07-05 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 縮合型アザ環の結晶形およびその調製プロセス（カンナビノイド受容体モジュレーター） |
| US10351576B2 (en) * | 2015-04-30 | 2019-07-16 | Novartis Ag | Fused tricyclic pyrazole derivatives useful for farnesoid X receptors |
| EP3402780A1 (en) | 2016-01-14 | 2018-11-21 | Beth Israel Deaconess Medical Center, Inc. | Mast-cell modulators and uses thereof |
| JP2021511364A (ja) * | 2018-01-29 | 2021-05-06 | カディラ ヘルスケア リミティド | 抗菌剤として有用な複素環式化合物 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3260721A (en) * | 1962-04-10 | 1966-07-12 | American Cyanamid Co | Heterocyclic derivatives of yohimbe alkaloids |
| EP0003115A1 (en) * | 1978-01-16 | 1979-07-25 | Sandoz Ag | Penicillins, per se and for use as antibacterially active antibiotics and their production |
| DE3374166D1 (en) | 1983-04-22 | 1987-12-03 | Mitsubishi Rayon Co | Apparatus for measuring gas partial pressure in living body |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2713225B1 (fr) | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| CA2106642C (en) * | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
| FR2714057B1 (fr) | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
| US5547975A (en) | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| FR2741621B1 (fr) | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2742148B1 (fr) | 1995-12-08 | 1999-10-22 | Sanofi Sa | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2758723B1 (fr) | 1997-01-28 | 1999-04-23 | Sanofi Sa | Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments |
| FR2761266B1 (fr) | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates |
| FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| FR2800375B1 (fr) | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
| FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
| FR2804604B1 (fr) | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac |
| FR2809621B1 (fr) | 2000-05-12 | 2002-09-06 | Sanofi Synthelabo | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles comme antidiarrheiques |
| FR2816938B1 (fr) | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| JP2005507875A (ja) | 2001-08-31 | 2005-03-24 | ユニバーシティ オブ コネチカット | カンナビノイド受容体に作用する新規なピラゾール類似体 |
| TWI231757B (en) | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
| WO2003026648A1 (en) | 2001-09-21 | 2003-04-03 | Solvay Pharmaceuticals B.V. | 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| ATE344663T1 (de) | 2001-09-21 | 2006-11-15 | Solvay Pharm Bv | Neue 4,5-dihydro-1h-pyrazol-derivate mit cb1- antagonistischer wirkung |
| US6509367B1 (en) | 2001-09-22 | 2003-01-21 | Virginia Commonwealth University | Pyrazole cannabinoid agonist and antagonists |
| CA2476665A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Tricyclic pyrazole derivatives for the treatment of inflammation |
| ITMI20041033A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Composti farmaceutici |
| EP1781668A2 (en) * | 2004-07-12 | 2007-05-09 | Cadila Healthcare Ltd. | Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
-
2005
- 2005-07-08 EP EP05815697A patent/EP1781668A2/en not_active Withdrawn
- 2005-07-08 MX MX2007000491A patent/MX2007000491A/es not_active Application Discontinuation
- 2005-07-08 JP JP2007520976A patent/JP2008505965A/ja not_active Withdrawn
- 2005-07-08 BR BRPI0513104-9A patent/BRPI0513104A/pt not_active IP Right Cessation
- 2005-07-08 NZ NZ552670A patent/NZ552670A/en not_active IP Right Cessation
- 2005-07-08 AU AU2005278781A patent/AU2005278781B2/en not_active Ceased
- 2005-07-08 UA UAA200700981A patent/UA88910C2/ru unknown
- 2005-07-08 GE GEAP20059851A patent/GEP20094682B/en unknown
- 2005-07-08 AP AP2007003880A patent/AP2228A/xx active
- 2005-07-08 NZ NZ580387A patent/NZ580387A/en not_active IP Right Cessation
- 2005-07-08 US US11/632,236 patent/US8030345B2/en not_active Expired - Fee Related
- 2005-07-08 CA CA2586011A patent/CA2586011C/en not_active Expired - Fee Related
- 2005-07-08 EA EA200700246A patent/EA011307B1/ru not_active IP Right Cessation
- 2005-07-08 EP EP10182912A patent/EP2343302A1/en not_active Withdrawn
- 2005-07-08 CN CNA200580030114XA patent/CN101014605A/zh active Pending
- 2005-07-08 KR KR1020077000654A patent/KR20070041717A/ko not_active Application Discontinuation
- 2005-07-08 WO PCT/IN2005/000237 patent/WO2006025069A2/en active Application Filing
-
2007
- 2007-01-05 ZA ZA200700162A patent/ZA200700162B/xx unknown
- 2007-01-10 IL IL180637A patent/IL180637A0/en unknown
- 2007-01-11 TN TNP2007000006A patent/TNSN07006A1/en unknown
- 2007-01-12 EC EC2007007167A patent/ECSP077167A/es unknown
- 2007-01-17 NO NO20070299A patent/NO20070299L/no not_active Application Discontinuation
-
2010
- 2010-04-29 US US12/769,861 patent/US20100273791A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0513104A (pt) | 2008-04-29 |
| WO2006025069A2 (en) | 2006-03-09 |
| US20100273791A1 (en) | 2010-10-28 |
| ECSP077167A (es) | 2007-05-30 |
| CA2586011A1 (en) | 2006-03-09 |
| WO2006025069A8 (en) | 2007-03-15 |
| CN101014605A (zh) | 2007-08-08 |
| AU2005278781A1 (en) | 2006-03-09 |
| UA88910C2 (ru) | 2009-12-10 |
| EP2343302A1 (en) | 2011-07-13 |
| TNSN07006A1 (en) | 2008-06-02 |
| AU2005278781B2 (en) | 2009-06-18 |
| JP2008505965A (ja) | 2008-02-28 |
| ZA200700162B (en) | 2009-09-30 |
| IL180637A0 (en) | 2007-06-03 |
| AP2228A (en) | 2011-04-01 |
| WO2006025069A3 (en) | 2006-04-27 |
| KR20070041717A (ko) | 2007-04-19 |
| EA200700246A1 (ru) | 2007-08-31 |
| NZ580387A (en) | 2011-06-30 |
| US8030345B2 (en) | 2011-10-04 |
| US20080051386A1 (en) | 2008-02-28 |
| NZ552670A (en) | 2010-02-26 |
| EP1781668A2 (en) | 2007-05-09 |
| CA2586011C (en) | 2011-07-19 |
| EA011307B1 (ru) | 2009-02-27 |
| GEP20094682B (en) | 2009-05-10 |
| AP2007003880A0 (en) | 2007-02-28 |
| MX2007000491A (es) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1919907T5 (da) | Heterocyklisk forbindelse | |
| DK1937650T3 (da) | Heterocykliske forbindelser | |
| ATE414693T1 (de) | Neuartige cis-imidazoline | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE404546T1 (de) | Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen | |
| ATE443056T1 (de) | Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| DE602004019555D1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone | |
| DK1812448T3 (da) | Organiske forbindelser | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| NO20070299L (no) | Novel heterocyclic compounds | |
| DE112005002826A5 (de) | Ausgleichseinheit | |
| DE602005004472D1 (de) | Ausgleichsanordnung | |
| ATE365731T1 (de) | 4-amino-5-cyanopyrimidinderivate | |
| ITMI20042238A1 (it) | Composti per fluoropolirterei | |
| ATE384719T1 (de) | Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen | |
| SE0402103D0 (sv) | Novel compounds | |
| SE0400022D0 (sv) | New compounds | |
| SE0400254D0 (sv) | New compounds | |
| SE0403054D0 (sv) | Novel compounds | |
| SE0402069D0 (sv) | Novel compounds | |
| SE0402068D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |